🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

H.B. Fuller Company FUL R2K

Basic Materials · Specialty Chemicals · United States
https://www.hbfuller.com

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

READ MORE ›
$64.08
+16.62% 1Y

Market & Price

Market Cap
$3.49B
Current Price
$64.08
High / Low (52W)
$67.21 / $49.09
Beta
0.94

Valuation

Stock P/E
22.17
Industry PE
24.80
Forward P/E
12.46
PEG Ratio
2.20
Book Value
$37.91
Price to Book
1.69
P/S
1.01
EV/EBITDA
9.58
Dividend Yield
1.53%

Profitability & Returns

ROCE
7.86%
ROE
8.32%
ROA
4.96%
Profit Margin
4.62%
Op Margin
8.40%
EPS (Latest Qtr)
$0.38
EPS (TTM)
$2.89

Balance Sheet & Liquidity

Debt/Equity
1.08
Quick Ratio
0.96
Current Ratio
1.92
Debt
$2.23B
Total Assets
$5.18B
Current Assets
$1.26B
Working Capital
$519.91M

Ownership

Promoter Holding
0.28%
Chg in Prom Hold
-
FII / Inst Holding
107.90%
Chg in FII Hold
0.11%

Financial Snapshot

Enterprise Value
$5.61B
Total Revenue (TTM)
$3.46B
EBITDA
$585.93M
Free Cash Flow
$205.81M
Operating Cash Flow
$312.43M
Shares Outstanding
54.49M
Gross Margin
31.88%
Payout Ratio
32.53%

Growth (CAGR)

Revenue 5Y
-2.51%
Profit 5Y
-5.54%
Revenue (YoY)
-2.30%
Earnings (YoY)
58.30%

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -2.5% CAGR over 5 years.
  • Earnings shrank at -5.5% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 FUL H.B. Fuller Company R2K 64.08 22.17 $3.49B 1.53% 7.86% 8.32% -2.51% -5.54%
2 LIN Linde plc NDXSPX 497.69 33.00 $230.11B 1.29% 13.07% 18.23% 0.62% 18.48%
3 NEM Newmont Corporation SPX 109.81 14.24 $117.23B 0.95% 22.51% 25.83% 23.91% 583.84%
4 FCX Freeport-McMoRan Inc. SPX 65.71 34.77 $94.46B 0.91% 12.93% 15.63% 4.39% -14.02%
5 SHW The Sherwin-Williams Company SPX 303.84 29.16 $74.94B 1.05% 20.04% 60.72% 2.10% 8.34%
6 CRH CRH plc SPX 108.79 20.18 $72.69B 1.43% 11.33% 15.81% 4.60% -1.15%
7 ECL Ecolab Inc. SPX 256.00 34.59 $72.05B 1.14% 14.89% 22.43% 4.26% 23.88%
8 APD Air Products and Chemicals, Inc. SPX 278.62 29.33 $62.04B 2.60% -0.62% 12.35% -1.77% -39.16%
9 NUE Nucor Corporation SPX 250.00 24.80 $56.94B 0.90% 8.80% 12.29% -7.84% -38.80%
Ad space

Quarterly Results

Figures in USD.

Metric Aug 2015Nov 2015Feb 2016May 2016Aug 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Aug 2019Nov 2019Feb 2020May 2020Aug 2020Nov 2020Feb 2021May 2021Aug 2021Feb 2022May 2022Aug 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Aug 2024Feb 2025Mar 2025May 2025Aug 2025Nov 2025Feb 2026
Revenue ------503.32M561.65M562.87M678.20M713.08M789.39M770.11M768.43M672.93M759.58M725.38M739.11M----------------788.66M-898.10M892.04M894.79M770.84M
Cost of Revenue ----------------------------------561.59M-611.71M606.93M612.71M534.80M
Gross Profit 146.84M156.06M137.60M158.26M146.12M167.82M139.63M146.53M150.12M168.79M185.51M220.19M215.03M207.43M179.93M218.46M207.32M201.22M170.26M184.90M187.84M213.64M192.36M217.55M193.95M212.89M253.52M249.16M214.81M256.77M263.47M239.24M282.05M275.73M227.07M227.07M286.38M285.11M282.08M236.05M
Operating Expenses ----------------------------------180.63M-186.34M174.97M160.83M184.45M
Operating Income 48.54M-37.84M54.57M48.43M-26.08M43.27M40.18M-32.81M73.30M67.29M-34.21M72.38M66.71M-28.75M56.90M58.73M-48.35M69.14M59.45M57.00M87.51M87.95M60.27M90.15M91.32M66.88M100.60M104.34M46.45M46.45M100.04M110.14M121.25M51.60M
EBITDA ----------------------------------93.35M-152.72M162.12M118.89M106.78M
Interest Expense ----------------------------------32.04M-34.87M33.63M32.81M32.87M
Pretax Income ----------------------------------18.71M-73.17M82.93M40.60M27.55M
Tax Provision ----------------------------------5.95M-32.73M16.53M11.93M7.42M
Net Income 26.81M-18.92M33.33M32.74M-14.79M25.87M25.14M-47.68M44.45M37.73M-12.24M36.64M49.72M32.21M9.89M31.61M41.61M40.60M29.79M49.10M31.62M38.31M47.20M46.50M21.89M40.40M37.63M30.99M51.26M55.36M13.25M13.25M41.83M67.16M29.73M21.05M
Diluted EPS 0.52-0.370.650.64-0.290.500.49-0.920.860.72-0.240.700.970.610.190.610.790.770.560.900.580.690.860.840.390.730.670.550.910.980.240.240.761.220.540.38

Profit & Loss (Annual)

Figures in USD.

Metric Nov 2008Nov 2009Nov 2010Dec 2011Dec 2012Nov 2013Nov 2014Nov 2015Dec 2016Dec 2017Dec 2018Nov 2019Nov 2020Nov 2021Nov 2022Dec 2022Nov 2023Dec 2023Nov 2024Nov 2025
Revenue --------2.09B2.31B3.04B2.90B--3.75B-3.51B-3.57B3.47B
Cost of Revenue --------------2.79B-2.50B-2.51B2.39B
Gross Profit 364.45M371.30M358.17M403.83M517.28M570.17M533.29M568.04M605.82M598.99M828.16M806.92M756.65M-963.70M963.70M1.01B1.01B1.06B1.08B
Operating Expenses --------------614.19M-633.51M-697.74M702.77M
Operating Income 2.79M107.16M94.62M116.96M162.54M195.50M149.84M170.49M198.18M119.53M237.89M225.99M218.32M-349.50M322.72M375.38M355.14M364.14M377.88M
EBITDA --------------490.43M-528.60M-490.50M527.08M
Interest Expense --------------91.52M-134.60M-133.12M133.35M
Pretax Income --------------251.93M-234.16M-182.66M215.42M
Tax Provision --------------77.19M-93.53M-56.38M67.13M
Net Income 18.89M83.65M70.88M89.11M125.62M96.76M49.77M86.68M121.66M59.42M171.21M130.82M123.72M-180.31M180.31M144.91M144.91M130.26M151.97M
Diluted EPS 0.361.701.431.792.481.890.971.692.371.153.292.522.36-3.263.262.592.592.302.75
R&D Expense -16.99M19.11M20.75M21.25M24.57M21.25M-------------

Compounded Sales Growth

5 Years:-2.51%
1 Year:-2.30%

Compounded Profit Growth

5 Years:-5.54%
1 Year:58.30%

Stock Price Performance

1 Year:+16.62%
6 Months:+10.49%
3 Months:-2.09%
1 Month:+7.53%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Nov 2008Nov 2009Nov 2010Dec 2011Dec 2012Nov 2013Nov 2014Nov 2015Dec 2016Dec 2017Dec 2018Nov 2019Nov 2020Nov 2021Dec 2021Nov 2022Dec 2022Nov 2023Dec 2023Nov 2024Nov 2025
Total Assets --1.10B1.15B1.23B1.79B1.87B1.87B2.04B2.06B4.37B4.18B3.99B4.04B-4.27B4.46B4.46B4.72B4.72B4.93B5.18B
Current Assets ----------------1.30B-1.31B-1.30B1.26B
Cash & Equivalents 246.36M80.37M98.65M154.65M154.65M200.44M155.12M77.57M119.17M142.25M194.40M150.79M112.19M100.53M-61.79M79.91M79.91M179.45M179.45M169.35M107.21M
Inventory ----------------491.78M-442.04M-467.50M471.96M
Receivables ----------------607.37M-577.93M-558.34M564.34M
Total Liabilities --506.20M519.07M518.25M1.00B937.85M973.90M1.16B1.11B3.32B3.02B2.76B2.65B-2.68B2.85B2.85B2.97B2.97B3.10B3.18B
Current Liabilities --236.01M231.33M254.99M350.12M360.78M317.20M349.52M391.84M504.91M546.12M542.16M530.13M-736.85M705.73M705.73M692.81M692.81M719.29M743.36M
Long Term Debt ---200.98M179.61M475.11M472.31M547.74M669.61M585.76M2.40B2.14B1.90B1.76B-1.59B1.74B1.74B1.84B1.84B2.01B2.02B
Total Debt ----------------1.80B-1.90B-2.07B2.08B
Total Equity --591.35M631.93M705.20M778.27M930.07M890.05M872.92M937.88M1.05B1.15B1.22B1.38B-1.60B1.61B1.61B1.76B1.76B1.83B2.00B
Shares Outstanding ----------------53.68M-54.09M-54.66M54.17M

Cash Flows (Annual)

Figures in USD.

Metric Nov 2008Nov 2009Nov 2010Dec 2011Dec 2012Nov 2013Nov 2014Nov 2015Dec 2016Dec 2017Dec 2018Nov 2019Nov 2020Nov 2021Nov 2022Dec 2022Nov 2023Dec 2023Nov 2024Nov 2025
Operating Cash Flow --------195.69M166.32M253.31M269.18M331.56M-256.51M256.51M378.40M378.40M302.44M263.49M
Investing Cash Flow ---------111.53M-1.80B-61.84M7.41M-109.46M--375.29M-375.29M-319.20M-319.20M-407.08M-232.25M
Financing Cash Flow ---------52.59M1.68B-228.60M-315.05M-239.21M-160.32M160.32M35.14M35.14M112.09M-107.90M
Capital Expenditure -19.96M-22.74M-31.73M-32.83M-35.91M-124.29M-139.79M-58.62M-63.31M-54.93M-68.26M-61.98M-87.29M--129.96M-129.96M-119.14M-119.14M-139.24M-142.28M
Free Cash Flow --------132.38M111.39M185.05M207.19M244.27M-126.55M126.55M259.26M259.26M163.20M121.22M
Net Change in Cash --------------41.55M-94.34M-7.45M-76.66M
Share Buybacks 200.75M362.00K377.00K8.51M4.33M17.64M15.51M19.29M23.23M21.83M4.69M3.03M3.43M2.68M-3.95M-2.57M39.56M60.71M

Ratios (Annual)

Figures in %.

Metric Nov 2008Nov 2009Nov 2010Dec 2011Dec 2012Nov 2013Nov 2014Nov 2015Dec 2016Dec 2017Dec 2018Nov 2019Nov 2020Nov 2021Nov 2022Dec 2022Nov 2023Dec 2023Nov 2024Nov 2025
Gross Margin % --------28.9%26.0%27.2%27.9%--25.7%-28.7%-29.8%31.1%
Operating Margin % --------9.5%5.2%7.8%7.8%--9.3%-10.7%-10.2%10.9%
Net Margin % --------5.8%2.6%5.6%4.5%--4.8%-4.1%-3.6%4.4%
ROE % -14.1%11.2%12.6%16.1%10.4%5.6%9.9%13.0%5.7%14.9%10.7%9.0%-11.2%11.2%8.3%8.3%7.1%7.6%
ROCE % -12.4%10.3%12.0%11.3%12.9%9.7%10.1%11.9%3.1%6.6%6.6%6.2%-9.3%8.6%9.3%8.8%8.6%8.5%

Shareholding Pattern

Insiders
0.28%
Institutions
107.90%
Public Float
108.20%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 14.74% 8.03M $514.60M
2 Vanguard Portfolio Management LLC 6.88% 3.75M $240.18M
3 State Street Corporation 5.06% 2.76M $176.62M
4 Dimensional Fund Advisors LP 4.79% 2.61M $167.12M
5 Capital World Investors 4.76% 2.59M $166.19M
6 Vanguard Capital Management LLC 4.46% 2.43M $155.77M
7 Mairs & Power Inc 4.33% 2.36M $151.33M
8 Kayne Anderson Rudnick Investment Management LLC 3.82% 2.08M $133.22M
9 Cooke & Bieler LP 2.87% 1.56M $100.15M
10 UBS Group AG 2.65% 1.44M $92.37M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for FUL

No recent headlines available.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks